Last reviewed · How we verify
NCT05246423: PLACEBO
Ergospirometry in Paroxysmal Atrial Fibrillation Prognosis
trial testing Observation group in Atrial Fibrillation in 80 participants. Status unknown.
10 December 2024
Quick facts
| Lead sponsor | Aristotle University Of Thessaloniki |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 10 December 2020 |
| Primary completion | 10 December 2024 |
| Estimated completion | 10 December 2024 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Observation group
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Atrial Arrhythmia — all drugs for Atrial Arrhythmia →
Sponsor
Aristotle University Of Thessaloniki
Who can join
18 and older, any sex, with Atrial Fibrillation or Atrial Arrhythmia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An observational, prospective, cohort study aiming to assess the potential predictive role of cardiopulmonary exercise testing in the prognosis of paroxysmal atrial fibrillation, in combination with echocardiographic indices and plasma biomarker values.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Exploring the Feasibility of Integrating Cardiopulmonary Exercise Testing, Echocardiography, and Biomarkers for Predicting Atrial Fibrillation Recurrence: Rationale, Design and Protocol for a Prospective Cohort Study (The PLACEBO Trial).
Boulmpou A, Moysiadis T, Zormpas G, Teperikidis E, et al · · 2025 · cited 2× · PMID 40095721 · DOI 10.3390/jcm14051690 -
Integrated Diagnostics for Atrial Fibrillation Recurrence: Exploratory Results from the PLACEBO Trial.
Boulmpou A, Moysiadis T, Zormpas G, Teperikidis E, et al · · 2025 · cited 1× · PMID 40361923 · DOI 10.3390/diagnostics15091105 -
Exploring the Role of Presepsin in the Prediction of Atrial Fibrillation Recurrence: Results from the PLACEBO Study.
Boulmpou A, Papadopoulos C, Koufakis T, Kotsa K, et al · · 2025 · PMID 41149083 · DOI 10.3390/diseases13100349
Verify or expand the search:
- PubMed search for NCT05246423
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observation group
Trials testing the same drug.
- NCT06890013 — A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Ac · recruiting
- NCT04617639 — The Norwegian Trial of Physical Exercise After Myocardial Infarction · NA · enrolling by invitation
- NCT03484975 — Novasight Hybrid Intravascular Ultrasound and Optical Coherence Tomography System (IVUS OCT) · NA · completed
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Aristotle University Of Thessaloniki trials
Trials by the same sponsor.
- NCT07382479 — NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery · NA · not yet recruiting
- NCT07379905 — MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) · NA · not yet recruiting
- NCT07335016 — The Role of Follicular Flushing at Oocyte Retrieval · NA · not yet recruiting
- NCT07297121 — Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece. · not yet recruiting
- NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05246423 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aristotle University Of Thessaloniki
- Last refreshed: 18 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05246423.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing